Home ETF List About

Portfolio Holdings Detail for ISIN IE00BD8KRH84
Stock Name / FundiShares Core S&P 500 UCITS ETF GBP Hedged (Dist)
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity Type
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerGSPX.LS(GBP) CXE
ETF TickerGSPX(GBP) Euronext Amsterdam

Holdings detail for INCY

Stock NameIncyte Corporation
TickerINCY(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS45337C1027
LEI549300Z4WN6JVZ3T4680

Show aggregate INCY holdings

News associated with INCY

Incyte Reaches Analyst Target Price
In recent trading, shares of Incyte Corporation (Symbol: INCY) have crossed above the average analyst 12-month target price of $84.18, changing hands for $84.80/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v - 2025-09-18 08:17:02
Incyte Reports Encouraging 24-Week Results From Phase 3 STOP-HS Program Of Povorcitinib
(RTTNews) - Incyte Corporation (INCY) on Wednesday announced encouraging 24-week data from the pivotal Phase 3 STOP-HS program evaluating povorcitinib in adults with hidradenitis suppurativa (HS). - 2025-09-17 03:26:09
Incyte Corporation (NASDAQ:INCY) Short Interest Update
Incyte Corporation (NASDAQ:INCY – Get Free Report) was the recipient of a significant increase in short interest during the month of August. As of August 15th, there was short interest totaling 9,600,000 shares, an increase of 29.4% from the July 31st total of 7,420,000 shares. Based on an average trading volume of 1,860,000 shares, the […] - 2025-09-11 04:51:36
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of “Hold” from Analysts
Incyte Corporation (NASDAQ:INCY – Get Free Report) has been assigned a consensus recommendation of “Hold” from the eighteen analysts that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and seven have issued a buy rating on the company. The […] - 2025-08-26 02:32:54
Incyte (NASDAQ:INCY) Given New $73.00 Price Target at JPMorgan Chase & Co.
Incyte (NASDAQ:INCY – Free Report) had its price objective increased by JPMorgan Chase & Co. from $67.00 to $73.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. A number of other research firms also recently commented on INCY. Citigroup upped their price objective on […] - 2025-08-25 03:08:46
LABU, INCY, UTHR, REGN: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Charles Schwab Investment Management Inc. Purchases 38,962 Shares of Incyte Corporation (NASDAQ:INCY)
Charles Schwab Investment Management Inc. raised its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 2.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,682,029 shares of the biopharmaceutical company’s stock after purchasing an additional 38,962 […] - 2025-08-13 05:43:01
XBI, ALNY, INSM, INCY: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $202.3 million dollar outflow -- that's a 4.3% decrease week over week - 2025-08-12 11:55:54
Citigroup Raises Incyte (NASDAQ:INCY) Price Target to $103.00
Incyte (NASDAQ:INCY – Get Free Report) had its price objective lifted by equities researchers at Citigroup from $88.00 to $103.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. Citigroup’s target price suggests a potential upside of 37.54% from the […] - 2025-08-01 04:32:55
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of “Hold” from Analysts
Shares of Incyte Corporation (NASDAQ:INCY – Get Free Report) have earned a consensus rating of “Hold” from the eighteen research firms that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, twelve have given a hold recommendation and five have assigned a buy recommendation to the […] - 2025-08-01 03:04:43
Incyte Reaches Analyst Target Price
In recent trading, shares of Incyte Corporation (Symbol: INCY) have crossed above the average analyst 12-month target price of $76.09, changing hands for $77.38/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v - 2025-07-30 10:12:59
Mutual of America Capital Management LLC Sells 478 Shares of Incyte Corporation (NASDAQ:INCY)
Mutual of America Capital Management LLC lessened its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 2.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 18,719 shares of the biopharmaceutical company’s stock after selling 478 shares during the quarter. […] - 2025-07-22 08:02:58
Incyte Corporation (NASDAQ:INCY) Shares Sold by Ballentine Partners LLC
Ballentine Partners LLC trimmed its position in Incyte Corporation (NASDAQ:INCY – Free Report) by 12.2% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 4,686 shares of the biopharmaceutical company’s stock after selling 649 shares during the quarter. Ballentine Partners LLC’s holdings in Incyte were worth $284,000 at the end of the most recent […] - 2025-07-17 05:12:56
Cerity Partners LLC Has $8.04 Million Stock Position in Incyte Corporation (NASDAQ:INCY)
Cerity Partners LLC lifted its holdings in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 103.5% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 132,703 shares of the biopharmaceutical company’s stock after buying an additional 67,495 shares during the period. Cerity Partners LLC owned […] - 2025-07-16 05:40:51
Incyte (NASDAQ:INCY) Price Target Cut to $67.00 by Analysts at JPMorgan Chase & Co.
Incyte (NASDAQ:INCY – Get Free Report) had its price objective decreased by equities research analysts at JPMorgan Chase & Co. from $68.00 to $67.00 in a report released on Monday,Benzinga reports. The firm currently has a “neutral” rating on the biopharmaceutical company’s stock. JPMorgan Chase & Co.‘s price objective would suggest a potential downside of […] - 2025-07-16 04:26:52
Sheila A. Denton Sells 599 Shares of Incyte Corporation (NASDAQ:INCY) Stock
Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Sheila A. Denton sold 599 shares of the company’s stock in a transaction that occurred on Wednesday, July 2nd. The shares were sold at an average price of $68.61, for a total value of $41,097.39. Following the completion of the sale, the executive vice president owned 26,504 […] - 2025-07-09 06:12:52
Incyte Corporation (NASDAQ:INCY) EVP Barry P. Flannelly Sells 10,903 Shares of Stock
Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Barry P. Flannelly sold 10,903 shares of the stock in a transaction that occurred on Thursday, July 3rd. The shares were sold at an average price of $68.15, for a total transaction of $743,039.45. Following the sale, the executive vice president directly owned 39,744 shares of the […] - 2025-07-08 06:54:44
Incyte Corporation (NASDAQ:INCY) EVP Sells $587,248.55 in Stock
Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Vijay K. Iyengar sold 8,617 shares of the company’s stock in a transaction dated Thursday, July 3rd. The stock was sold at an average price of $68.15, for a total transaction of $587,248.55. Following the completion of the sale, the executive vice president directly owned 37,701 shares […] - 2025-07-08 06:20:54
Incyte Corporation (NASDAQ:INCY) Shares Sold by Vontobel Holding Ltd.
Vontobel Holding Ltd. trimmed its holdings in Incyte Corporation (NASDAQ:INCY – Free Report) by 16.8% in the first quarter, Holdings Channel.com reports. The institutional investor owned 7,875 shares of the biopharmaceutical company’s stock after selling 1,592 shares during the quarter. Vontobel Holding Ltd.’s holdings in Incyte were worth $477,000 as of its most recent filing […] - 2025-07-08 04:46:50
Sumitomo Mitsui Trust Group Inc. Purchases 25,844 Shares of Incyte Corporation (NASDAQ:INCY)
Sumitomo Mitsui Trust Group Inc. increased its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 5.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 473,186 shares of the biopharmaceutical company’s stock after purchasing an additional 25,844 shares […] - 2025-07-03 05:25:07
Incyte Corporation (NASDAQ:INCY) Shares Purchased by Chevy Chase Trust Holdings LLC
Chevy Chase Trust Holdings LLC raised its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 0.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 84,241 shares of the biopharmaceutical company’s stock after purchasing an additional 334 shares during the quarter. […] - 2025-06-27 05:36:52
Janney Montgomery Scott LLC Boosts Stock Position in Incyte Corporation (NASDAQ:INCY)
Janney Montgomery Scott LLC grew its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 10.2% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 29,793 shares of the biopharmaceutical company’s stock after purchasing an additional 2,746 shares during the period. Janney Montgomery Scott LLC’s holdings in Incyte were worth $1,804,000 as of its […] - 2025-06-27 04:26:49
State of Alaska Department of Revenue Purchases 590 Shares of Incyte Corporation (NASDAQ:INCY)
State of Alaska Department of Revenue lifted its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 3.2% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,824 shares of the biopharmaceutical company’s stock after acquiring an additional 590 shares […] - 2025-06-26 05:56:50
Kentucky Retirement Systems Insurance Trust Fund Makes New Investment in Incyte Corporation (NASDAQ:INCY)
Kentucky Retirement Systems Insurance Trust Fund bought a new stake in Incyte Corporation (NASDAQ:INCY – Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 4,624 shares of the biopharmaceutical company’s stock, valued at approximately $280,000. A number […] - 2025-06-26 05:03:09
Incyte Corporation (NASDAQ:INCY) Shares Acquired by Wealth Enhancement Advisory Services LLC
Wealth Enhancement Advisory Services LLC lifted its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 66.5% during the 1st quarter, HoldingsChannel.com reports. The fund owned 79,735 shares of the biopharmaceutical company’s stock after acquiring an additional 31,851 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Incyte were worth $4,828,000 […] - 2025-06-26 04:30:52
Assenagon Asset Management S.A. Has $536,000 Stock Position in Incyte Corporation (NASDAQ:INCY)
Assenagon Asset Management S.A. raised its position in Incyte Corporation (NASDAQ:INCY – Free Report) by 37.6% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,846 shares of the biopharmaceutical company’s stock after acquiring an additional 2,418 shares during the period. […] - 2025-06-20 04:54:50
Incyte Corporation (NASDAQ:INCY) Shares Sold by Exchange Traded Concepts LLC
Exchange Traded Concepts LLC lowered its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 41.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 18,117 shares of the biopharmaceutical company’s stock after selling 12,867 shares during the period. Exchange Traded Concepts […] - 2025-06-19 05:43:03
Fifth Third Bancorp Has $551,000 Holdings in Incyte Corporation (NASDAQ:INCY)
Fifth Third Bancorp raised its holdings in Incyte Corporation (NASDAQ:INCY – Free Report) by 2.0% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 9,103 shares of the biopharmaceutical company’s stock after acquiring an additional 179 shares during the quarter. Fifth Third Bancorp’s holdings in Incyte were worth $551,000 at the end of […] - 2025-06-18 04:56:49
Incyte (NASDAQ:INCY) Raised to “Buy” at Stifel Nicolaus
Incyte (NASDAQ:INCY – Get Free Report) was upgraded by equities researchers at Stifel Nicolaus from a “hold” rating to a “buy” rating in a research report issued on Monday, MarketBeat reports. The brokerage currently has a $107.00 price objective on the biopharmaceutical company’s stock, up from their previous price objective of $75.00. Stifel Nicolaus’ price […] - 2025-06-18 02:22:54
Stocks Settle Higher on Possible De-Escalation of Israel-Iran War
The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.94%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.42%. June E-mini S&P futures (ESM25 ) are up +1.00%, and June E-mini Nasdaq futures... - 2025-06-17 13:23:43

iShares Core S&P 500 UCITS ETF GBP Hedged (Dist) INCY holdings

DateNumber of INCY Shares HeldBase Market Value of INCY SharesLocal Market Value of INCY SharesChange in INCY Shares HeldChange in INCY Base ValueCurrent Price per INCY Share HeldPrevious Price per INCY Share Held
2025-11-12 (Wednesday)380,299USD 41,171,170USD 41,171,170
2025-11-11 (Tuesday)380,299USD 41,133,140INCY holding increased by 829052USD 41,133,1400USD 829,052 USD 108.16 USD 105.98
2025-11-10 (Monday)380,299INCY holding increased by 176USD 40,304,088INCY holding increased by 18652USD 40,304,088176USD 18,652 USD 105.98 USD 105.98
2025-11-07 (Friday)380,123USD 40,285,436INCY holding increased by 296496USD 40,285,4360USD 296,496 USD 105.98 USD 105.2
2025-11-06 (Thursday)380,123INCY holding decreased by -105USD 39,988,940INCY holding decreased by -201160USD 39,988,940-105USD -201,160 USD 105.2 USD 105.7
2025-11-05 (Wednesday)380,228INCY holding decreased by -66USD 40,190,100INCY holding increased by 1050242USD 40,190,100-66USD 1,050,242 USD 105.7 USD 102.92
2025-11-04 (Tuesday)380,294INCY holding decreased by -279USD 39,139,858INCY holding increased by 485058USD 39,139,858-279USD 485,058 USD 102.92 USD 101.57
2025-11-03 (Monday)380,573USD 38,654,800INCY holding increased by 3078836USD 38,654,8000USD 3,078,836 USD 101.57 USD 93.48
2025-10-31 (Friday)380,573INCY holding decreased by -44USD 35,575,964INCY holding increased by 334636USD 35,575,964-44USD 334,636 USD 93.48 USD 92.59
2025-10-30 (Thursday)380,617INCY holding increased by 154USD 35,241,328INCY holding increased by 931175USD 35,241,328154USD 931,175 USD 92.59 USD 90.18
2025-10-29 (Wednesday)380,463INCY holding increased by 154USD 34,310,153INCY holding decreased by -545167USD 34,310,153154USD -545,167 USD 90.18 USD 91.65
2025-10-28 (Tuesday)380,309INCY holding increased by 660USD 34,855,320INCY holding decreased by -482409USD 34,855,320660USD -482,409 USD 91.65 USD 93.08
2025-10-27 (Monday)379,649INCY holding increased by 352USD 35,337,729INCY holding increased by 715499USD 35,337,729352USD 715,499 USD 93.08 USD 91.28
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of INCY by Blackrock for IE00BD8KRH84

Show aggregate share trades of INCY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY176108.810104.070 104.544USD 18,400 72.13
2025-11-06SELL-105106.430103.075 103.410USD -10,858 71.79 Loss of -3,320 on sale
2025-11-05SELL-66106.470101.500 101.997USD -6,732 71.62 Loss of -2,005 on sale
2025-11-04SELL-279103.860100.020 100.404USD -28,013 71.46 Loss of -8,076 on sale
2025-10-31SELL-4495.10092.058 92.362USD -4,064 71.19 Loss of -932 on sale
2025-10-30BUY15494.62091.190 91.533USD 14,096 71.08
2025-10-29BUY15490.18094.420 93.996USD 14,475 70.98
2025-10-28BUY66091.65093.980 93.747USD 61,873 70.87
2025-10-27BUY35293.08093.170 93.161USD 32,793 70.75
2025-10-24BUY4491.28092.080 92.000USD 4,048 70.64
2025-10-23SELL-8889.31089.560 89.535USD -7,879 70.55 Loss of -1,671 on sale
2025-10-22BUY17688.06088.210 88.195USD 15,522 70.45
2025-10-21BUY6687.30087.480 87.462USD 5,772 70.36
2025-10-17BUY33087.57088.540 88.443USD 29,186 70.18
2025-10-16BUY2287.31092.860 92.305USD 2,031 70.09
2025-10-14SELL-13285.96086.160 86.140USD -11,370 69.90 Loss of -2,144 on sale
2025-10-07BUY66087.17087.950 87.872USD 57,996 69.80
2025-10-06BUY2287.23088.300 88.193USD 1,940 69.71
2025-10-03BUY30886.85086.980 86.967USD 26,786 69.61
2025-10-02BUY24286.28088.660 88.422USD 21,398 69.52
2025-10-01BUY15486.70087.240 87.186USD 13,427 69.42
2025-09-30BUY22084.81085.310 85.260USD 18,757 69.33
2025-09-29BUY19883.89084.410 84.358USD 16,703 69.25
2025-09-26BUY24282.70082.950 82.925USD 20,068 69.17
2025-09-25BUY30881.66084.450 84.171USD 25,925 69.10
2025-09-24BUY1,14484.16084.820 84.754USD 96,959 69.01
2025-09-18BUY2286.00086.070 86.063USD 1,893 68.91
2025-09-17BUY19884.80085.980 85.862USD 17,001 68.81
2025-09-16BUY8883.90084.580 84.512USD 7,437 68.72
2025-09-15BUY22083.14083.660 83.608USD 18,394 68.64
2025-09-11BUY11086.17087.100 87.007USD 9,571 68.53
2025-09-09BUY11085.60087.350 87.175USD 9,589 68.32
2025-08-12BUY6681.61081.820 81.799USD 5,399 68.13
2025-08-11BUY19879.19079.720 79.667USD 15,774 68.06
2025-08-08BUY50678.39079.000 78.939USD 39,943 68.00
2025-08-07BUY6678.20078.250 78.245USD 5,164 67.93
2025-08-01BUY39675.59075.690 75.680USD 29,969 67.88
2025-07-31BUY2274.89077.460 77.203USD 1,698 67.84
2025-07-30BUY17677.55078.770 78.648USD 13,842 67.78
2025-07-29BUY2277.38077.870 77.821USD 1,712 67.72
2025-07-14BUY17669.98070.040 70.034USD 12,326 67.70
2025-07-11SELL-4468.59069.970 69.832USD -3,073 67.70 Loss of -94 on sale
2025-07-10BUY17670.34070.620 70.592USD 12,424 67.68
2025-07-09BUY17668.72069.300 69.242USD 12,187 67.67
2025-07-08BUY13267.67068.650 68.552USD 9,049 67.67
2025-07-07SELL-50667.27068.250 68.152USD -34,485 67.67 Loss of -242 on sale
2025-07-02SELL-63868.17069.100 69.007USD -44,026 67.66 Loss of -859 on sale
2025-06-30BUY37468.10068.820 68.748USD 25,712 67.66
2025-06-27BUY19868.37071.120 70.845USD 14,027 67.65
2025-06-25SELL-4467.55069.140 68.981USD -3,035 67.63 Loss of -59 on sale
2025-06-24BUY2269.01069.540 69.487USD 1,529 67.62
2025-06-23BUY57267.26068.780 68.628USD 39,255 67.62
2025-06-20SELL-6668.46069.190 69.117USD -4,562 67.62 Loss of -99 on sale
2025-06-18SELL-13268.27069.470 69.350USD -9,154 67.61 Loss of -230 on sale
2025-06-13SELL-6667.75068.960 68.839USD -4,543 67.60 Loss of -82 on sale
2025-06-12BUY6669.22069.540 69.508USD 4,588 67.59
2025-06-11BUY8868.85070.360 70.209USD 6,178 67.58
2025-06-06SELL-11068.77068.980 68.959USD -7,585 67.53 Loss of -157 on sale
2025-06-05SELL-6667.24067.870 67.807USD -4,475 67.53 Loss of -18 on sale
2025-06-04SELL-8867.42068.450 68.347USD -6,015 67.53 Loss of -72 on sale
2025-06-02BUY28665.31065.970 65.904USD 18,849 67.55
2025-05-30SELL-6365.06065.770 65.699USD -4,139 67.57 Profit of 118 on sale
2025-05-29BUY2266.04066.260 66.238USD 1,457 67.59
2025-05-28SELL-2264.93065.610 65.542USD -1,442 67.61 Profit of 45 on sale
2025-05-27BUY24265.35065.800 65.755USD 15,913 67.63
2025-05-23SELL-44064.25064.570 64.538USD -28,397 67.68 Profit of 1,384 on sale
2025-05-22SELL-48464.51065.330 65.248USD -31,580 67.71 Profit of 1,191 on sale
2025-05-21BUY2264.78065.460 65.392USD 1,439 67.73
2025-05-20BUY17665.30066.110 66.029USD 11,621 67.76
2025-05-19BUY63863.81064.300 64.251USD 40,992 67.79
2025-05-16BUY59463.31063.480 63.463USD 37,697 67.83
2025-05-15BUY48462.76062.990 62.967USD 30,476 67.87
2025-05-14BUY44061.16062.500 62.366USD 27,441 67.93
2025-05-13SELL-8860.81061.150 61.116USD -5,378 68.00 Profit of 605 on sale
2025-05-12BUY2260.85061.410 61.354USD 1,350 68.06
2025-05-09BUY6658.98060.480 60.330USD 3,982 68.14
2025-05-08SELL-63859.73059.990 59.964USD -38,257 68.22 Profit of 5,267 on sale
2025-05-07SELL-30859.55060.070 60.018USD -18,486 68.30 Profit of 2,551 on sale
2025-05-06BUY77059.61062.510 62.220USD 47,909 68.38
2025-05-02BUY6662.53062.870 62.836USD 4,147 68.50
2025-05-01SELL-11062.03062.640 62.579USD -6,884 68.56 Profit of 658 on sale
2025-04-30BUY6662.66062.870 62.849USD 4,148 68.62
2025-04-29BUY15460.43060.720 60.691USD 9,346 68.70
2025-04-28BUY32859.52059.600 59.592USD 19,546 68.79
2025-04-25BUY30859.16059.210 59.205USD 18,235 68.88
2025-04-24BUY8858.97059.050 59.042USD 5,196 68.98
2025-04-23BUY24258.00059.010 58.909USD 14,256 69.10
2025-04-22SELL-13457.38058.040 57.974USD -7,769 69.22 Profit of 1,506 on sale
2025-04-17BUY4458.21058.690 58.642USD 2,580 69.58
2025-04-16BUY8857.73058.780 58.675USD 5,163 69.71
2025-04-15BUY44058.46059.950 59.801USD 26,312 69.83
2025-04-11BUY55056.87057.070 57.050USD 31,377 70.09
2025-04-10BUY90255.17058.330 58.014USD 52,329 70.26
2025-04-09BUY17658.86059.370 59.319USD 10,440 70.39
2025-04-08BUY46256.97061.470 61.020USD 28,191 70.55
2025-04-07BUY52760.29061.060 60.983USD 32,138 70.67
2025-04-04SELL-1,32060.58063.570 63.271USD -83,518 70.78 Profit of 9,917 on sale
2025-04-02BUY15462.33062.530 62.510USD 9,627 70.88
2025-03-31SELL-59460.55060.810 60.784USD -36,106 71.13 Profit of 6,147 on sale
2025-03-28SELL-37460.60060.970 60.933USD -22,789 71.26 Profit of 3,863 on sale
2025-03-27SELL-11060.68061.640 61.544USD -6,770 71.39 Profit of 1,084 on sale
2025-03-26BUY19861.26062.880 62.718USD 12,418 71.52
2025-03-25SELL-26462.08063.270 63.151USD -16,672 71.64 Profit of 2,242 on sale
2025-03-24BUY15462.78063.310 63.257USD 9,742 71.76
2025-03-21BUY26461.92062.330 62.289USD 16,444 71.89
2025-03-19BUY4260.34061.150 61.069USD 2,565 72.20
2025-03-18SELL-39660.00061.030 60.927USD -24,127 72.36 Profit of 4,529 on sale
2025-03-17BUY41862.01063.450 63.306USD 26,462 72.51
2025-03-14BUY37467.86068.120 68.094USD 25,467 72.57
2025-03-13BUY1,84667.71068.970 68.844USD 127,086 72.64
2025-03-12BUY88067.73068.230 68.180USD 59,998 72.71
2025-03-11BUY35268.07071.650 71.292USD 25,095 72.78
2025-03-07BUY20870.79072.810 72.608USD 15,102 72.84
2025-03-06SELL-19870.09070.980 70.891USD -14,036 72.88 Profit of 394 on sale
2025-03-05BUY68469.81069.970 69.954USD 47,849 72.93
2025-03-04BUY13269.68070.000 69.968USD 9,236 72.98
2025-03-03BUY59470.26073.450 73.131USD 43,440 73.02
2025-02-28SELL-15473.50073.630 73.617USD -11,337 73.02 Loss of -93 on sale
2025-02-27BUY2273.18074.600 74.458USD 1,638 73.01
2025-02-26SELL-4474.30075.310 75.209USD -3,309 72.99 Loss of -98 on sale
2025-02-25BUY41874.40076.240 76.056USD 31,791 72.97
2025-02-21BUY30872.11072.970 72.884USD 22,448 72.96
2025-02-20BUY17671.38071.520 71.506USD 12,585 72.99
2025-02-19BUY4470.16071.430 71.303USD 3,137 73.04
2025-02-18BUY11071.27071.680 71.639USD 7,880 73.08
2025-02-13BUY37470.01072.690 72.422USD 27,086 73.25
2025-02-12BUY13269.05069.100 69.095USD 9,121 73.33
2025-02-11SELL-4466.33068.690 68.454USD -3,012 73.48 Profit of 221 on sale
2025-02-07SELL-17674.13076.960 76.677USD -13,495 73.58 Loss of -546 on sale
2025-02-06BUY8874.95075.490 75.436USD 6,638 73.55
2025-02-04BUY77074.12074.920 74.840USD 57,627 73.49
2025-02-03BUY28673.74075.000 74.874USD 21,414 73.49
2025-01-31BUY6674.16075.180 75.078USD 4,955 73.47
2025-01-30BUY4473.77074.560 74.481USD 3,277 73.46
2025-01-29BUY41873.72074.110 74.071USD 30,962 73.46
2025-01-28BUY19873.15073.990 73.906USD 14,633 73.46
2025-01-27BUY30872.64073.430 73.351USD 22,592 73.49
2025-01-24BUY19872.59073.680 73.571USD 14,567 73.51
2025-01-23BUY57272.53072.880 72.845USD 41,667 73.54
2025-01-22BUY37472.41073.550 73.436USD 27,465 73.57
2024-12-10BUY15472.48073.100 73.038USD 11,248 73.60
2024-12-09BUY17672.11075.980 75.593USD 13,304 73.65
2024-12-06BUY26475.92076.460 76.406USD 20,171 73.58
2024-12-05BUY6674.92075.370 75.325USD 4,971 73.53
2024-12-04BUY24274.62075.320 75.250USD 18,211 73.50
2024-12-03BUY77672.03072.960 72.867USD 56,545 73.55
2024-12-02BUY6573.24074.700 74.554USD 4,846 73.56
2024-11-29BUY50674.59076.080 75.931USD 38,421 73.52
2024-11-27BUY59475.45076.140 76.071USD 45,186 73.36
2024-11-26BUY1,27674.80074.950 74.935USD 95,617 73.30
2024-11-25BUY1,32073.52073.870 73.835USD 97,462 73.29
2024-11-22BUY1,54071.72072.000 71.972USD 110,837 73.36
2024-11-21BUY24270.39071.400 71.299USD 17,254 73.51
2024-11-20BUY22071.05071.680 71.617USD 15,756 73.64
2024-11-19BUY19870.56074.100 73.746USD 14,602 73.81
2024-11-18BUY1,78276.97077.010 77.006USD 137,225 73.62
2024-11-12BUY61680.58082.020 81.876USD 50,436 73.19
2024-11-11BUY41881.53083.540 83.339USD 34,836 72.63
2024-11-08BUY31683.38083.950 83.893USD 26,510 71.87
2024-11-07BUY1,95882.34082.970 82.907USD 162,332 71.06
2024-11-06BUY59480.95082.190 82.066USD 48,747 70.24
2024-11-05BUY87677.28077.370 77.361USD 67,768 69.60
2024-11-04BUY15475.75076.570 76.488USD 11,779 68.98
2024-11-01BUY35276.13076.330 76.310USD 26,861 68.19
2024-10-31BUY8874.12074.680 74.624USD 6,567 67.44
2024-10-30BUY21973.93074.600 74.533USD 16,323 66.52
2024-10-29BUY52873.60074.070 74.023USD 39,084 65.34
2024-10-28SELL-15465.69065.880 65.861USD -10,143 65.27 Loss of -91 on sale
2024-10-25BUY26465.07065.740 65.673USD 17,338 65.32
2024-10-24BUY17665.24065.910 65.843USD 11,588 65.34
2024-10-23BUY22065.17066.100 66.007USD 14,522 65.43
2024-10-22BUY56965.59065.780 65.761USD 37,418 65.27
2024-10-21BUY61665.27066.550 66.422USD 40,916 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of INCY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19321,923395451,11071.4%
2025-09-18244,9471,423469,74752.1%
2025-09-17277,858779546,95350.8%
2025-09-16359,781946576,37962.4%
2025-09-15347,4534582,22859.7%
2025-09-12353,0400631,53455.9%
2025-09-11448,7333,894739,70160.7%
2025-09-10490,727248671,93273.0%
2025-09-09515,3951,822682,79175.5%
2025-09-08308,184119479,82864.2%
2025-09-05256,7192,505512,04950.1%
2025-09-04422,6241,507834,71750.6%
2025-09-03381,6797,777624,92261.1%
2025-09-02547,12015,396816,26767.0%
2025-08-29148,294262304,42748.7%
2025-08-28164,0080347,48047.2%
2025-08-27248,926453513,40148.5%
2025-08-26365,1306709,32051.5%
2025-08-25478,1301,306642,31974.4%
2025-08-22344,3522,023596,30157.7%
2025-08-21198,7294,881335,30159.3%
2025-08-20351,6993,977555,34563.3%
2025-08-19343,1103,146574,32859.7%
2025-08-18366,1244,996653,10356.1%
2025-08-15480,8858,035625,79776.8%
2025-08-14593,55436,654806,06873.6%
2025-08-13845,18198,1601,257,50367.2%
2025-08-12462,89642,208678,68968.2%
2025-08-11385,211696595,89264.6%
2025-08-08248,925738426,18758.4%
2025-08-07268,864929420,48663.9%
2025-08-06554,642891731,48475.8%
2025-08-05361,6872,092623,87958.0%
2025-08-04338,0051,464519,15065.1%
2025-08-01414,814828572,87972.4%
2025-07-31570,8456,148777,41773.4%
2025-07-30471,30314,166881,19453.5%
2025-07-29966,64010,5811,593,70160.7%
2025-07-28382,23662625,51061.1%
2025-07-25216,96749422,99051.3%
2025-07-24348,27623528,51765.9%
2025-07-23297,903583487,29761.1%
2025-07-22267,987172446,48960.0%
2025-07-21223,626380406,72955.0%
2025-07-18241,218108471,58951.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.